Innovaderma Share Discussion Threads

[donald pond] 05/5/2021 10:41

Social restrictions lifting but foreign holdings tricky, especially for the 16-35 cohort that won't be vaccinated but like a tan. Could be a good opportunity here

[brumm1875] 04/5/2021 14:09

I also took my share of the open offer and tried to buy some more in the excess offer but only received 13% of what I wanted so, in my case, big scale back. Seems to confirm the statement from the company which said that the offer was multiple time over subscribed. Looking forward to a good “tanning”; season ahead for Skinny Tan.

[kinwah] 04/5/2021 12:23

There was a little bit of interesting press after the PZ Cussons trading statement. The Times spoke to Jonathan Myers the PZ ceo. To quote, There was said to be "a real pick-up in demand" in its St Tropez self-tanning brand as socialising restrictions were being lifted. I'd expect Skinny Tan to be flying off the shelves this week. I stagged the open offer and topped up again this morning. The next trading update should be good.

[kemche] 29/4/2021 12:29

The Open Offer was significantly oversubscribed and the Directors will use their discretion to undertake an appropriate scaling back process.

[jg88721] 29/4/2021 09:48

that's not a trading update as it says NOTHING about current trading. just some general speculation/commentary about what might happen in future in the market.

[cockerhoop] 27/4/2021 16:31

Well the mk cap will grow by 50% (at the current price) to £11m when they've issued the new paper :-)

[doc robinson] 27/4/2021 15:06

Placing and open offer completes this week once out the way should move fast as stated only. 7 mil at current price

[doc robinson] 27/4/2021 10:06

Once placing and open offer complete successfully these should move strongly with new management at the helm . At 7 million market cap appears on the low side with some very strong brands. Good time to top up.?

[donald pond] 19/4/2021 20:11

Only £7m market cap so absolutely huge scope for growth and a board motivated to achieve it. Not one to bet the farm on but a very decent long shot imo

[ali47fish] 19/4/2021 18:18

zip i dont follow - what do you mean?

[zipstuck] 19/4/2021 17:17

Tricky. The need to get the open offer away so buying shares ahead is a way of doing it.

[ishwar] 19/4/2021 15:42

He will be having 18% plus interest post the new shares allocation I think based on some quick calc the other daySeems trending in a good way

[boonkoh] 19/4/2021 11:57

Although tbh he was already £500k "exposed" to Innovaderma with his directors loan. So just converting debt for equity. But still a good vote of confidence going debt>equity. He could have just pocketed the repayments and not participated in the placing.

[shandypants2] 19/4/2021 11:55

Lord Loads - Life Sciences barely got a mention in the recent presentation and new CEO has just completed a strategic review. Prolong revenues are low and not rising and Headmaster/Growlase doesn't seem to be going anywhere. Both probably need a fair bit of marketing spend. Reading between the lines it looks like this will be sold if they can get a decent price - ex founder Haris was the inspiration behind LS and he has c£5m in his pocket from his 40% of shares sold over a 2 year period. I wouldn't be surprised if he was interested in buying

[ishwar] 16/4/2021 18:07

YesMy bad Very significant indeed

[boonkoh] 16/4/2021 12:04

You forgot the most important part!Mark Ward is participating in the 35p placing, picking up £490k worth of shares.

[ishwar] 16/4/2021 11:11

NewsDirector/PDMR shareholdingInnovaDerma (LSE: IDP), a UK developer of beauty, personal care and life sciences products, announces it was notified yesterday that, Mark Ward, Non-executive Director has purchased 171,242 Ordinary shares of EUR0.10 each in the Company at an average price of 40.7 pence per Ordinary Share.

[pugugly] 16/4/2021 08:18

LLL 23201 - Very fair summary -

[ishwar] 15/4/2021 17:48

Seems good volume for the share

[lord loads of lolly] 15/4/2021 17:24

shandypants2- Life Sciences is the bit I actually think could become MOST valuable for IDP. Margins are huge and they had some decent contractual deals in the pipeline in Asia, before Covid hit. I take your point about it not being core, but I still hope they hang onto it.

[shandypants2] 15/4/2021 16:30

Next 6 months - not 56 months!!!

[shandypants2] 15/4/2021 16:28

IMHO i would take up the offer as the price must be close to the bottom and the upside potential is significant.
The placing is all but done so IDP has the extra money now and a new BOD who seem to be the right calibre to take this forward.
ST is a well respected brand with nearly 1m followers across FB, Insta etc. At last accounts stock was c£4m in value so c 50% of current valuation. ST alone must be conservatively worth £10m, so you get everything else for free.
Re-looking at H1 results it is clear that Joe B has run this into the ground - based in Oz he lost control of UK operations so rev was massively down, margins were lower but marketing spend was still quite high. Madness. He also booted out the previous CEO who seemed quite switched on, clearly because he disagreed with Joe's approach - this cost IDP £107k as per accounts, probably 6 months salary.
New BOD has already said they will write down some intangibles - currently c£8m on the balance sheet so YE P/L will not look great. BOD may also look to get rid of Life Sciences as it doesn't seem to be core.
Next 56 months may not be great, but in next 12 to 18 months hopefully this will be in a better shape.

[cockerhoop] 15/4/2021 16:26

Mark Ward is basically getting his £500k loan back in shares at 35p so in effect a CLN.

Handy NED to have as IDP would have probably run out of road without his loan.

I think there's value in the brands (CRL interest proves that) the jury's out as to whether this management can exploit it.

[lord loads of lolly] 15/4/2021 16:06

muzmanoz - Think I read £4m of the £4.5m open offer (i.e the total available to NON-PIs) was oversubscribed. In which case administration ain't on the cards (not yet at least). It's an interesting one. I plan to wait until the very last moment (22 April) to see how the share price moves before deciding whether to take up. I'm inclined to double up because 1) Having rejected Creightons' offer out of hand, management must either be incredibly confident they can do better themselves - or hopelessly arrogant. 2) Late last year, NED Mark Ward bought another £270K worth of shares at 70p each. OK, so his timing wasn't great. But he's certainly no slouch. He's also a multi-millionaire from the takeover of his former empire (Hunter Macdonald) and is a real IT whizz which bodes well for IDP. As of Feb 21, he held 12.5% or just shy of 17.4 million IDP shares. And I believe following the open offer, his total holding will be just north of 13%. I've been saying for a while my biggest fear is if he takes IDP private before it's fully recovered (assuming it ever does), then enjoys most of the upside at the expense of long-suffering small investors. I believe that's still a big risk, as the company seems quite dependent on him to bankroll things short-term. But hopefully the open offer will change that. My other main concern is that with peak tanning season running from now to end June, and lockdown only gradually being eased, full year results may disappoint. But as others have said, with fewer people flying off to sunnier climes this summer, there may be increased demand for self tanning products given the vagaries of our British summer.